Enjoy 30% off select life science products with free shipping and giveaways with promo code: RESEARCH30 Offer ends October 2, 2020.
Supporting Our Customers, Employees and Partners During COVID-19
The COVID-19 outbreak has impacted lives on a global scale. MP Biomedicals remains committed to serving key industries in critical pharmaceutical, diagnostic and chemical production. Most importantly, we are prioritizing the health and safety of our customers, employees and partners.
Our team is here to help. Please contact us anytime for questions or support.
As an essential business, MP Biomedicals is continuing our operations globally to best service our customers, suppliers and partners during COVID-19. We have implemented additional measures to keep our employees safe and continue to follow all public health recommendations and guidelines around the world. Many of our employees are working remotely, but are still available to answer your questions, provide support and help scientists continue their valuable research.
MP Biomedicals is working diligently with our suppliers and production teams to ensure minimal disruptions to our supply chain. We understand how important it is to deliver quality products, on-time. Our goal is to minimize impact to our customers and partners by maintaining complete transparency. View our offering of COVID-19 essential products for research and manufacturing applications.
MP Bio has clear awareness of our social responsibilities during the COVID-19 pandemic. We are prioritizing the safety of our employees and customers while also supporting local communities. We are fortunate to have a secure supply of PPE and have already donated to several local hospitals and medical facilities, including Cleveland Clinic, University Hospitals and The Brooklyn Hospital Center. Please contact us if your facility is in need of supplies.
MP Biomedicals FastPrep® Instruments help expedite COVID-19 current vaccine research with INOVIO Pharmaceuticals, University of Oxford and CSIRO in Australia.
We are proud to see the FastPrep-24 Classic has been instrumental in SARS-CoV-2 therapeutic research. INOVIO Pharmaceuticals, together with University of Oxford and researchers at Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia, were featured on 9 News Australia showcasing their COVID-19 vaccine development.